TRCT
AVAH icon

Tower Research Capital (TRC)’s Aveanna Healthcare AVAH Stock Holding History

Tower Research Capital (TRC)’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
5,035
+2,298
+84% +$16.2K ﹤0.01% 2856
2026
Q1 		$17.6K Buy
2,737
+542
+25% +$4.19K ﹤0.01% 3570
2025
Q4 		$17.9K Buy
2,195
+1,126
+105% +$10.2K ﹤0.01% 3182
2025
Q3 		$9.48K Sell
1,069
-4,815
-82% -$30.4K ﹤0.01% 4026
2025
Q2 		$30.8K Buy
5,884
+1,165
+25% +$5.92K ﹤0.01% 3379
2025
Q1 		$25.6K Sell
4,719
-3,170
-40% -$15K ﹤0.01% 2749
2024
Q4 		$36.1K Buy
7,889
+6,854
+662% +$35.1K ﹤0.01% 2772
2024
Q3 		$5.38K Sell
1,035
-12,960
-93% -$58.6K ﹤0.01% 4284
2024
Q2 		$38.6K Buy
13,995
+6,653
+91% +$16.6K ﹤0.01% 3295
2024
Q1 		$18.3K Buy
7,342
+2,254
+44% +$5.44K ﹤0.01% 3076
2023
Q4 		$13.6K Sell
5,088
-26,406
-84% -$50.4K ﹤0.01% 3948
2023
Q3 		$37.5K Buy
31,494
+25,782
+451% +$39.9K ﹤0.01% 2820
2023
Q2 		$9.65K Sell
5,712
-5,203
-48% -$6.53K ﹤0.01% 4241
2023
Q1 		$11K Sell
10,915
-4,232
-28% -$5.03K ﹤0.01% 4182
2022
Q4 		$12K Sell
15,147
-26,007
-63% -$27.2K ﹤0.01% 3675
2022
Q3 		$62K Buy
41,154
+37,367
+987% +$76.8K ﹤0.01% 2967
2022
Q2 		$8K Buy
3,787
+1,295
+52% +$3.75K ﹤0.01% 4653
2022
Q1 		$8K Sell
2,492
-1,531
-38% -$8.31K ﹤0.01% 4554
2021
Q4 		$30K Buy
4,023
+2,295
+133% +$16.7K ﹤0.01% 3210
2021
Q3 		$13K Buy
1,728
+831
+93% +$8.05K ﹤0.01% 4065
2021
Q2 		$11K Buy
+897
New +$10.6K ﹤0.01% 4311

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Tower Research Capital (TRC)'s AVAH Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Aveanna Healthcare (AVAH) stake by 84% in Q2 2026, buying an estimated $16.2K and bringing the position to 5,035 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

Tower Research Capital (TRC) first reported a position in AVAH in Q2 2021 and has held it in 21 quarters since. The position peaked at $62K in Q3 2022. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Tower Research Capital (TRC) held 5,035 shares of Aveanna Healthcare worth $43.1K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,298 Aveanna Healthcare shares in Q2 2026, an estimated $16.2K.
  • Aveanna Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2856 holding.
  • Tower Research Capital (TRC) first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Aveanna Healthcare position peaked at $62K in Q3 2022.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.